Analytical Data
-
基因名
MSS51
- Application
-
别名
Putative protein MSS51 homolog. mitochondrial. Zinc finger MYND domain-containing protein 17
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q4VC12
-
表达区间
1-460 aa
-
氨基酸序列
MAPRSRRRRHKKPPSSVAPIIMAPTTIVTPVPLTPSKPGPSIDTLGFFSLDDNVPGLSQLILQKLNMKSYEEYKLVVDGGTPVSGFGFRCPQEMFQRMEDTFRFCAHCRALPSGLSDSKVLRHCKRCRNVYYCGPECQKSDWPAHRRVCQELRLVAVDRLMEWLLVTGDFVLPSGPWPWPPEAVQDWDSWFSMKGLHLDATLDAVLVSHAVTTLWASVGRPRPDPDVLQGSLKRLLTDVLSRPLTLGLGLRALGIDVRRTGGSTVHVVGASHVETFLTRPGDYDELGYMFPGHLGLRVVMVGVDVATGFSQSTSTSPLEPGTIQLSAHRGLYHDFWEEQVETGQTHHPDLVAAFHPGFHSSPDLMEAWLPTLLLLRDYKIPTLITVYSHQELVSSLQILVELDTHITAVGSNPFMSLKPEQVYSSPNKQPVYCSAYYIMFLGSSCQLDNRQLEEKVDGGI
-
分子量
77.6 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MSS51 is a crucial recombinant protein that has garnered attention in the field of molecular biology due to its role in mitochondrial translation and cell metabolism. Initially identified in yeast, it has been acknowledged for its potential involvement in the assembly of mitochondrial ribosomes and regulation of mitochondrial gene expression. The study of MSS51 is particularly relevant as mitochondrial dysfunction is implicated in various human diseases, including neurodegenerative disorders and metabolic syndromes. By exploring the structure and function of MSS51, researchers aim to elucidate its mechanisms at the molecular level, which could pave the way for developing therapeutic strategies targeting mitochondrial-related diseases. Furthermore, the production of MSS51 as a recombinant protein allows for in-depth studies regarding its interactions with other mitochondrial components, offering insights into mitochondrial biogenesis and protein synthesis. This understanding is vital as it may unlock new avenues for research in bioenergetics and contribute to the development of treatments for conditions stemming from mitochondrial dysfunction. Overall, the investigation of MSS51 not only enhances our comprehension of mitochondrial biology but also holds promise for future medical advancements.
